Oncotarget

Research Papers:

Prognostic significance of FAM83D gene expression across human cancer types

Peter J. Walian, Bo Hang and Jian-Hua Mao _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:3332-3340. https://doi.org/10.18632/oncotarget.6620

Metrics: PDF 7370 views  |   HTML 1237 views  |   ?  


Abstract

Peter J. Walian1, Bo Hang1, Jian-Hua Mao1

1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94127, USA

Correspondence to:

Jian-Hua Mao, e-mail: JHMao@lbl.gov

Keywords: FAM83D, prognosis, human cancer, genetic instability

Received: July 21, 2015     Accepted: November 20, 2015     Published: December 15, 2015

ABSTRACT

The family with sequence similarity 83, member D (FAM83D) gene has been proposed as a new prognostic marker for breast cancer. Here we further evaluate the prognostic significance of FAM83D expression in different breast cancer subtypes using a meta-analysis. Patients with higher FAM83D mRNA levels have significantly decreased overall and metastatic relapse-free survival, particularly in the group of patients with ER-positive, or luminal subtype tumors. We also assessed FAM83D alterations and its prognostic significance across 22 human cancer types using The Cancer Genome Atlas (TCGA). FAM83D is frequently gained in the majority of human cancer types, resulting in the elevated expression of FAM83D. Higher levels of FAM83D mRNA expression are significantly associated with decreased overall survival in several cancer types. Finally, we demonstrate that TP53 mutation in human cancers is coupled to a significant increase in the expression of FAM83D, and that a higher level of FAM83D expression is positively correlated with an increase in genome instability in many cancer types. These results identify FAM83D as a potential novel oncogene across multiple human cancer types.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6620